In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2

Elisabeth Castellanos; Inma Rosas; Ares Solanes; Isabel Bielsa; Conxi Lázaro; Cristina Carrato; C. Hostalot; Pepe Prades; Francesc Roca-Ribas; Ignacio Blanco; Eduard Serra

doi:10.1038/ejhg.2012.261

In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2

Elisabeth Castellanos(Institute of Predictive and Personalized Medicine of Cancer), Inma Rosas(Institute of Predictive and Personalized Medicine of Cancer), Ares Solanes(Institut Català d'Oncologia), Isabel Bielsa(Hospital Universitari Germans Trias i Pujol), Conxi Lázaro(Institut Català d'Oncologia), Cristina Carrato(Hospital Universitari Germans Trias i Pujol), C. Hostalot(Hospital Universitari Germans Trias i Pujol), Pepe Prades(Hospital Universitari Germans Trias i Pujol), Francesc Roca-Ribas(Hospital Universitari Germans Trias i Pujol), Ignacio Blanco(Institut Català d'Oncologia), Eduard Serra(Institute of Predictive and Personalized Medicine of Cancer)

European Journal of Human Genetics

November 28, 2012

10.1038/ejhg.2012.261

Cited by 25Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis